Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Study sponsor: Lakefront Biotherapeutics NV · LKFT
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-08-01Actual
Enrollment · participants1188Actual
Source updated2024-07-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.